New Evidence on the Impact of Antithrombotics in Patients Submitted to Small Bowel Capsule Endoscopy for the Evaluation of Obscure Gastrointestinal Bleeding

Table 1

Baseline patients’ characteristics and antithrombotic use.

Characteristics, (%)
Age (y), median (range)	61.9 (19–91)
Female	170 (62.0)
Occult OGIB	225 (82.1)
Visible OGIB	49 (17.9)
Hemoglobin (g/dL), median (range)	9.3 (4.2–15.1)
Diabetes mellitus	79 (28.8)
Chronic kidney disease	29 (10.6)
Arterial hypertension	140 (51.1)
Ischaemic heart disease	54 (19.7)
Antithrombotic drug use, (%)
Antithrombotics	104 (38.0)
Antiplatelet alone	60 (21.9)
Aspirin	45 (16.4)
Thienopyridine	11 (4.0)
Both	4 (1.5)
Anticoagulant alone	31 (11.3)
Heparin/LMWH	15 (5.4)
Warfarin/acenocoumarol	16 (5.8)
Both	13 (4.7)